In this issue:
Cyclophosphamide + glucocorticoids in acute IPF exacerbation
Trends in urban NO2 and associated paediatric asthma incidence
Clinical phenotypes and outcomes of SARS-COV-2 and other respiratory viruses
Worldwide trends in asthma symptom burden in school-aged children
Early remdesivir to prevent progression to severe COVID-19
Effect of nusinersen on respiratory function in paediatric SMA types 1–3
Azithromycin for chronic cough in IPF
Baricitinib for hospitalised adults with COVID-19
Inhaled treprostinil in PH-ILD:multiple disease progression events
Effect of HFNC oxygen therapy on exercise tolerance in IPF
Please login below to download this issue (PDF)